icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Efficacy of Boceprevir in Prior Null Responders to Peginterferon/Ribavirin: The PROVIDE Study
 
 
  Reported by Jules Levin
AASLD Nov 5-8 2011 SF
 
J. Vierling1, S. Flamm2, S. Gordon3, E. Lawitz4, J-P. Bronowicki5, M. Davis6, E. Yoshida7, L.D. Pedicone8, W. Deng8, M. Treitel8, C. Brass8, J. Albrecht8, and I. Jacobson9
1Baylor College of Medicine, Houston, TX; 2Northwestern Feinberg School of Medicine, Chicago, IL; 3Henry Ford Hospital, Detroit, MI; 4Alamo Medical Research, San Antonio, TX; 5University Henri Poincare of Nancy, Vandoeuvre-les-Nancy, France; 6South Florida Center of Gastroenterology, Wellington, FL; 7University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada; 8Merck Sharp & Dohme Corp., Whitehouse Station, NJ; 9Weill Cornell Medical College, New York, NY

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif